Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Liquid dressing with cervical postoperative hemostasis function and infection prevention function and application

A liquid dressing and infection prevention technology, applied in dressings, viscous dressings, medical science, etc., can solve the problems of secondary bleeding, difficult wound healing, inconvenience, etc., and achieve the effect of accelerating repair and regeneration, and inhibiting the reproduction of pathogens

Inactive Publication Date: 2021-10-26
克尔维特(福州)医疗科技有限公司
View PDF6 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, there are many ways and means of hemostasis and repair of medical wounds and wounds, including various physical methods, chemical methods, hydrogels, etc. These methods have their own advantages and disadvantages. Adhesion to the wound surface is prone to occur, causing secondary bleeding, and it is inconvenient; some vaginal administration gels contain water in the ingredients, and the water-containing gel will cause wounds and wounds are not easy to heal, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Liquid dressing with cervical postoperative hemostasis function and infection prevention function and application
  • Liquid dressing with cervical postoperative hemostasis function and infection prevention function and application
  • Liquid dressing with cervical postoperative hemostasis function and infection prevention function and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] A liquid dressing with hemostatic function after cervical surgery and infection prevention, comprising the following components by weight: 1.5 parts of carbomer, 10 parts of microporous bioactive glass, 45 parts of medical glycerin, 40 parts of propylene glycol, chitosan 1.5 parts, 0.6 parts of sodium hyaluronate, 0.15 parts of triclosan and 0.01 parts of recombinant human epidermal growth factor.

Embodiment 2

[0032] A liquid dressing with hemostatic function and infection prevention after cervical surgery, comprising the following components in parts by weight: 1 part of carbomer, 25 parts of microporous bioactive glass, 30 parts of medical glycerin, 25 parts of propylene glycol, chitosan 0.5 part, 1.0 part of sodium hyaluronate, 0.05 part of triclosan and 0.2 part of recombinant human epidermal growth factor.

Embodiment 3

[0034] A liquid dressing with hemostatic function and infection prevention after cervical surgery, comprising the following components by weight: 2 parts of carbomer, 2 parts of microporous bioactive glass, 70 parts of medical glycerin, 60 parts of propylene glycol, chitosan 2.5 parts, 0.1 part of sodium hyaluronate, 0.25 part of triclosan and 0.1 part of recombinant human epidermal growth factor.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
weightaaaaaaaaaa
weightaaaaaaaaaa
weightaaaaaaaaaa
Login to View More

Abstract

The invention discloses a liquid dressing with a cervical postoperative hemostasis function and an infection prevention function. The liquid dressing is prepared from the following components in parts by weight: 1-2 parts of carbomer, 2-25 parts of microporous bioactive glass, 30-70 parts of medical glycerol, 25-60 parts of propylene glycol, 0.5-2.5 parts of chitosan, 0.1-1.0 part of sodium hyaluronate, 0.05-0.25 part of triclosan and 0.01-0.2 part of recombinant human epidermal growth factor; wound exudate is absorbed through the adsorption effect of the microporous bioglass; the bioactive glass and the chitosan have the functions of stopping bleeding and promoting healing, and bleeding is reduced; and the triclosan has the sterilization and bacteriostasis effects, so that infection is prevented, wound healing is promoted, and the liquid dressing is a functional medical product with a wide application prospect.

Description

technical field [0001] The invention relates to the technical field of liquid dressings, in particular to a liquid auxiliary material which has hemostatic function after cervical surgery and prevents wound infection. Background technique [0002] The proportion of women suffering from cervical diseases is very high, among which more than half of women of childbearing age suffer from cervicitis, about 70% of women have been infected with HPV virus in their lifetime, and about 10% show persistent infection, and then in 5- Between 15 years, it gradually developed into precancerous lesions and even cervical cancer. HPV infection and cervicitis are closely related to the occurrence of cervical cancer. With the popularization of cancer prevention knowledge and national multi-cancer screening, more and more patients require examination and treatment, and the methods are constantly being explored and updated. The main methods of treatment are: cervical smear, cervical biopsy, micro...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61L26/00A61F13/02
CPCA61L26/0014A61L26/0023A61L26/0004A61L26/00A61L26/0066A61F13/0206A61F13/0259A61F13/00051A61F13/00063A61L2400/04A61L2300/236A61L2300/412A61L2300/404A61L2300/216A61L2300/414A61L2300/112A61L2300/41C08L33/02C08L5/08
Inventor 陈海云任丽琴林俊锦
Owner 克尔维特(福州)医疗科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products